|
⚲
|
| Keyboard |
| Outer Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002138797 |
| Sale | 2024-06-28 (23.3 M Offered, 23.3 M Sold) |
| Fund | |
| Phone | 5083199620 |
| Address | 200 Exchange Street Malden, MA 02148 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-08-21 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Sara Choi | Director | |
| Stefani Germanotta | Director | |
| Polansky Michael | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Boston Hill Advisors LLC
✚
|
MA | |
|
Navemar Capital Management LP
✚
|
MA | |
|
Venus Capital Management Inc
✚
|
MA | |
|
Perennial Capital Advisors LLC
✚
|
MA | |
|
Catch Point Rights Partners LP
✚
|
MA | |
|
Boston Partners
✚
|
MA | |
|
Third Rock Ventures LLC
✚
|
MA | |
|
Three BAYS Capital LP
✚
|
MA | |
|
Nextview Management Company LLC
✚
|
MA | |
|
M33 Growth LLC
✚
|
MA |